Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for PERINDOPRIL ERBUMINE

Ingredient

PERINDOPRIL ERBUMINE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-PERINDOPRIL-INDAPAMIDE	8MG 2.5MG	TABLET	Resolved	2024-06-20	2024-11-22	231027
APO-PERINDOPRIL-INDAPAMIDE	8MG 2.5MG	TABLET	Resolved	2022-04-29	2022-06-28	159713
APO-PERINDOPRIL-INDAPAMIDE	1.25MG 4MG	TABLET	Resolved	2022-09-01	2022-09-23	168424
APO-PERINDOPRIL-INDAPAMIDE	1.25MG 4MG	TABLET	Resolved	2023-02-09	2023-09-22	184092
APO-PERINDOPRIL-INDAPAMIDE	1.25MG 4MG	TABLET	Resolved	2023-07-13	2023-12-22	198505
APO-PERINDOPRIL-INDAPAMIDE	1.25MG 4MG	TABLET	Resolved	2024-07-25	2024-11-22	233709
APO-PERINDOPRIL-INDAPAMIDE	1.25MG 4MG	TABLET	Resolved	2024-12-19	2025-01-17	246056
APO-PERINDOPRIL-INDAPAMIDE	1.25MG 4MG	TABLET	Resolved	2025-03-27	2025-08-01	253496
APO-PERINDOPRIL-INDAPAMIDE	1.25MG 4MG	TABLET	Actual shortage	2025-05-15	2025-07-17	257403
APO-PERINDOPRIL-INDAPAMIDE	8MG 2.5MG	TABLET	Avoided shortage	2023-03-09	2023-09-15	186580

Previous
1
2
3
4
5
6
…
12
Next

Showing 31 to 40 of 113

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0